SALA DE IMPRENSA
20487_FP_Header_Newsroom_Website_2400x900px

As últimas notícias da Dr. Falk Pharma

Bem-vindo à nossa Sala de Imprensa que fornece as últimas notícias, comunicados de imprensa, anúncios de ensaios clínicos, eventos e muito mais da Dr. Falk Pharma.

Siga-nos no LinkedIn!

Evento

EASL 2025

Join us from 7 – 10 May 2025 at the EASL Congress 2025 in Amsterdam, the Netherlands or online.

Institucional, Indicações

Today is World Liver Day!

Did you know that our first product back in 1960 was a therapeutic drug for the liver?

Institucional

Following the footsteps of our founder - The End

Elena looks back and summarizes her journey: it's a collection of emotional encounters, funny moments, and, most of all, it's a big THANK YOU!

Evento

Back to the Future – Unleashing the Power of Established Drugs

Lunch satellite symposium on 21.02.2025 during the Congress of ECCO in Berlin

Institucional

Merry Christmas

... and all the best for 2025!

Institucional

Elena em Portugal

... onde se encontrou com o Prof. Dr. Fernando J. Magro Dias no Porto.

Estudo

Burden of disease of Primary Sclerosing Cholangitis

A Retrospective Cohort Study in Germany

Institucional, Comunicado de Imprensa

Dr. Falk Pharma acquires Kynos Therapeutics

...adding acute pancreatitis as a therapeutic focus and further strengthening its development portfolio

Evento

UEG Week 2024

We look forward to seeing you on booth 46 in Vienna from October 12 – 15, 2024!

Institucional

Seguindo os passos do nosso fundador

A neta de Herbert Falk, Elena, decidiu seguir os passos do avô. Porquê? Saiba mais e siga a Elena na sua viagem.

Institucional

Em memória do nosso fundador

Faz hoje 100 anos que nasceu o Dr. Dr. Herbert Falk

Evento

EASL 2024

From 5-8 June 2024 in Milan - we look forward to seeing you (exhibition space E2)

Comunicado de Imprensa

FDA clearance of IND application for naronapride

...to treat gastroparesis and subsequent expansion of ongoing phase 2b study to the US

Institucional

Hoje é o Dia das Doenças Raras

Já ouviu falar de EoE, CBP ou CEP?

Comunicado de Imprensa

Advancing the development of naronapride...

...for patients with PPI-non-responsive symptomatic GERD as the second naronapride indication

Evento

ECCO 2024

Satellite Symposium "Navigating Ulcerative Proctitis" on 23.02.2024

Institucional

Feliz Natal

...e boas festas

Institucional

Parcerias

Sobre nós e nossos Innovation Champions

Institucional

Moonshot Thinking

An evening with Daniel Cronin and lots of ideas!

Institucional, Indicações

Hoje é o Dia Mundial da DII!

Teste os seus conhecimentos e saiba mais sobre a DII

Institucional, Indicações

Rare Disease Day

As the experts in digestive and metabolic medicine, our focus is also on rare diseases.

Institucional, Evento

ECCO Congress 2023

In Copenhagen, Denmark, from March 1 – 4, 2023.

Institucional

3000 LinkedIn-Followers!

Thank you very much!
Together we know more. Together we do more.

Institucional, Comunicado de Imprensa

Initiation of Phase II Study of naronapride in patients with gastroparesis

Renexxion Ireland and Dr. Falk Pharma announce that the first patient has been treated

Institucional

Merry Christmas

We wish you happy holidays and all the best for 2023

Institucional

New Work in Freiburg

Pilot space to find out which elements & spaces work for us

Institucional, Comunicado de Imprensa

Collaboration and Licensing Agreement with Takeda and Zedira

To Develop First-in-Class Celiac Disease Therapy

Logo UEG Week
Evento

UEG Week 2022

Join us from October 8 – 11 in Vienna on booth no. 43 or virtually!

Logo Zedira
Comunicado de Imprensa, Estudo

NAFLD: Phase 2a proof of concept study of ZED1227

Dr. Falk Pharma and Zedira announce trial start for the treatment of non-alcoholic fatty liver disease. First patient enrolled in April.

Evento

International Liver Congress™ in London

We are proud to be a sponsor and look forward to seeing you in person on our booth no. 69 or online, 22-26 June 2022!

Evento

Digestive Disease Week® 2022

We look forward to 2 exciting presentations on day 4 of this year’s DDW!

Comunicado de Imprensa, Indicações

Have difficulty swallowing food?

Difficulty swallowing and pain while eating may be warning signs of eosinophilic esophagitis (EoE). The first EoE Day will be held on May 22, 2022.

Institucional, Comunicado de Imprensa

Resposta à crise da Ucrânia

A Dr. Falk Pharma apoia a APOTHEKER HELFEN e.V.

Institucional, Comunicado de Imprensa

O futuro começa aqui

Planos concluídos para o futuro Falk Campus em Freiburgo

ECCO logo 2022
Evento

ECCO 2022

Online, from February 16 to 19, 2022. We look forward to seeing you!

Prometheus Logo
Comunicado de Imprensa

Together we advance PR600

Investigational New Drug Application for PR600 expected in 3Q 2022.